- Filed
- Dec 10, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Dec 3, 2024 | 63.96M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 63.84M sh |
| Shares Diluted | Q2 2025 · Oct 31, 2024 | 63.74M sh |
| Capex | Q2 2025 · Oct 31, 2024 | $4.76M |
| Operating Cash Flow | Q2 2025 · Oct 31, 2024 | $314K |
| Long Term Debt | Q2 2025 · Oct 31, 2024 | $52.87M |
| Cash And Equivalents | Q2 2025 · Oct 31, 2024 | $33.42M |
| Cash And Equivalents | Q2 2025 · Apr 30, 2024 | $38.11M |
| Stockholders Equity | Q2 2025 · Oct 31, 2024 | $44.81M |
| Stockholders Equity | Q2 2025 · Jul 31, 2024 | $58.64M |
| Stockholders Equity | Q2 2025 · Apr 30, 2024 | $60.89M |
| Current Liabilities | Q2 2025 · Oct 31, 2024 | $74.16M |
| Current Liabilities | Q2 2025 · Apr 30, 2024 | $70.57M |
| Total Liabilities | Q2 2025 · Oct 31, 2024 | $278.67M |
| Total Liabilities | Q2 2025 · Apr 30, 2024 | $275.67M |
| Current Assets | Q2 2025 · Oct 31, 2024 | $96.51M |
| Current Assets | Q2 2025 · Apr 30, 2024 | $104M |
| Total Assets | Q2 2025 · Oct 31, 2024 | $323.48M |
| Total Assets | Q2 2025 · Apr 30, 2024 | $336.56M |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | −$0.27 |
| Eps Diluted | Q2 2025 · Oct 31, 2024 | −$0.36 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | −$0.27 |
| Eps Basic | Q2 2025 · Oct 31, 2024 | −$0.36 |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $10.59M |
| Sga Expense | Q2 2025 · Oct 31, 2024 | $18.76M |
| Net Income | Q2 2025 · Oct 31, 2024 | −$17.41M |
| Net Income | Q2 2025 · Oct 31, 2024 | −$22.94M |
| Operating Income | Q2 2025 · Oct 31, 2024 | −$12.63M |
| Operating Income | Q2 2025 · Oct 31, 2024 | −$15.09M |
| Gross Profit | Q2 2025 · Oct 31, 2024 | −$2.05M |
| Gross Profit | Q2 2025 · Oct 31, 2024 | $3.67M |
| Revenue | Q2 2025 · Oct 31, 2024 | $33.48M |
| Revenue | Q2 2025 · Oct 31, 2024 | $73.66M |